Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors
Open Access
- 23 May 2022
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 11 (24) , 4880-4888
Abstract
Background & aims: Immune checkpoint inhibitors (ICIs) play an increasingly important role in the treatment of primary liver cancer (PLC). Some patients with PLC experience symptoms of splenomegaly. Splenomegaly may affect the efficacy of ICIs due to an imbalance of the immune microenvironment. Currently, there is a lack of evidence on the relationship between splenomegaly and prognosis in patients with PLC treated with ICIs. This study analyzed the relationship between splenomegaly and prognosis in patients with PLC treated with ICIs.Methods: In this retrospective cohort study of 161 patients with PLC treated with ICIs, splenomegaly was diagnosed using computed tomography or magnetic resonance imaging and the impact of splenomegaly on patient survival was analyzed.Results: Through univariate and multivariate Cox regression analyses, we determined that splenomegaly was associated with shortened overall survival (p = 0.002) and progression‐free survival (p = 0.013) in patients with PLC treated with ICIs. Kaplan–Meier analysis further validated our results. The overall survival and progression‐free survival of patients with splenomegaly were significantly shorter than those of patients without splenomegaly (p < 0.01 and p = 0.02, respectively).Conclusions: We concluded that splenomegaly was a predictor of prognosis in patients with PLC treated with ICIs. This is the first study to report this important finding.Keywords
Funding Information
- Southern Medical University
- National Natural Science Foundation of China (81972897, 81773008)
This publication has 28 references indexed in Scilit:
- The spleen in liver cirrhosis: revisiting an old enemy with novel targetsJournal of Translational Medicine, 2017
- The yin and yang of evasion and immune activation in HCCJournal of Hepatology, 2015
- Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directionsHepatology, 2014
- Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertensionJournal of Hepatology, 2010
- Splenomegaly: Investigation, diagnosis and managementBlood Reviews, 2009
- Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES)Surgical Endoscopy, 2008
- Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments?British Journal of Radiology, 2002
- Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.2001
- Anemia as an independent prognostic factor for survival in patients with cancerCancer, 2001
- Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher diseaseBritish Journal of Haematology, 1999